{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:08:21Z","timestamp":1792516101605,"version":"4.5.0"},"reference-count":109,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,2,15]]},"DOI":"10.1001\/jama.2022.0358","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T12:18:17Z","timestamp":1644927497000},"page":"662","source":"Crossref","is-referenced-by-count":766,"title":["Diagnosis and Treatment of Acute Coronary Syndromes"],"prefix":"10.1001","volume":"327","author":[{"given":"Deepak L.","family":"Bhatt","sequence":"first","affiliation":[{"name":"Brigham and Women\u2019s Hospital Heart and Vascular Institute, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Harrington","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"22","key":"jrv220002r1","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1161\/CIR.0000000000001030","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"144","author":"Gulati","year":"2021","journal-title":"Circulation"},{"issue":"14","key":"jrv220002r2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"issue":"3","key":"jrv220002r3","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001038","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines.","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"20","key":"jrv220002r4","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"issue":"10065","key":"jrv220002r5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","article-title":"Acute myocardial infarction.","volume":"389","author":"Reed","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"jrv220002r6","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics 2020 update: a report from the American Heart Association.","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"jrv220002r7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0002-9149(02)02489-X","article-title":"Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE).","volume":"90","author":"Steg","year":"2002","journal-title":"Am J Cardiol"},{"issue":"14","key":"jrv220002r8","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I.","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"jrv220002r9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ahj.2013.04.010","article-title":"Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non-ST-segment elevation acute coronary syndromes.","volume":"166","author":"Tan","year":"2013","journal-title":"Am Heart J"},{"issue":"4","key":"jrv220002r10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s strategic Impact Goal through 2020 and beyond.","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"jrv220002r11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e356","article-title":"25 Year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study.","volume":"344","author":"Schmidt","year":"2012","journal-title":"BMJ"},{"issue":"14","key":"jrv220002r12","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2009.07.022","article-title":"Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis.","volume":"54","author":"Meyers","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"jrv220002r13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.118.037137","article-title":"Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction.","volume":"139","author":"Arora","year":"2019","journal-title":"Circulation"},{"issue":"20","key":"jrv220002r14","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1001\/jama.2018.5281","article-title":"Percutaneous coronary intervention in 2018.","volume":"319","author":"Bhatt","year":"2018","journal-title":"JAMA"},{"issue":"7","key":"jrv220002r15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.9649","article-title":"Association of smoking cessation and survival among young adults with myocardial infarction in the partners YOUNG-MI registry.","volume":"3","author":"Biery","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"jrv220002r16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jacc.2019.11.025","article-title":"Marijuana use in patients with cardiovascular disease: JACC review topic of the week.","volume":"75","author":"DeFilippis","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"jrv220002r17","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1016\/j.jacc.2018.02.047","article-title":"Cocaine and marijuana use among young adults with myocardial infarction.","volume":"71","author":"DeFilippis","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"jrv220002r18","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1161\/01.CIR.103.23.2805","article-title":"Triggering myocardial infarction by marijuana.","volume":"103","author":"Mittleman","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"jrv220002r19","first-page":"101","article-title":"Acute coronary syndrome in the older adults.","volume":"13","author":"Dai","year":"2016","journal-title":"J Geriatr Cardiol"},{"issue":"18","key":"jrv220002r20","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1001\/jama.2020.2047","article-title":"Rural-urban differences in cardiovascular mortality in the us, 1999-2017.","volume":"323","author":"Cross","year":"2020","journal-title":"JAMA"},{"issue":"24","key":"jrv220002r21","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1161\/CIRCULATIONAHA.119.041297","article-title":"Resource and infrastructure-appropriate management of st-segment elevation myocardial infarction in low- and middle-income countries.","volume":"141","author":"Chandrashekhar","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"jrv220002r22","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jcin.2015.02.026","article-title":"A combined optical coherence tomography and intravascular ultrasound study on plaque rupture, plaque erosion, and calcified nodule in patients with st-segment elevation myocardial infarction: incidence, morphologic characteristics, and outcomes after percutaneous coronary intervention.","volume":"8","author":"Higuma","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"41","key":"jrv220002r23","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1093\/eurheartj\/ehx418","article-title":"Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.","volume":"38","author":"Khan","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"jrv220002r24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/hrt.82.3.269","article-title":"Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction.","volume":"82","author":"Arbustini","year":"1999","journal-title":"Heart"},{"key":"jrv220002r25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2020.11.005","article-title":"Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule.","volume":"318","author":"Sugane","year":"2021","journal-title":"Atherosclerosis"},{"issue":"7","key":"jrv220002r26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jacc.2008.04.050","article-title":"Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study.","volume":"52","author":"Ong","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"jrv220002r27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.000795","article-title":"Clinical features and prognosis of patients with coronary spasm-induced non-ST-segment elevation acute coronary syndrome.","volume":"3","author":"Nakayama","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"jrv220002r28","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/eurheartj\/ehz007","article-title":"Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes.","volume":"40","author":"Saw","year":"2019","journal-title":"Eur Heart J"},{"issue":"2","key":"jrv220002r29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcin.2017.08.057","article-title":"Coronary embolus: an underappreciated cause of acute coronary syndromes.","volume":"11","author":"Raphael","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"jrv220002r30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009174","article-title":"Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): results from the VIRGO study.","volume":"7","author":"Safdar","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"18","key":"jrv220002r31","doi-asserted-by":"publisher","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association.","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"jrv220002r32","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014733","article-title":"Sex differences in symptom presentation in acute coronary syndromes: a systematic review and meta-analysis.","volume":"9","author":"van Oosterhout","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"jrv220002r33","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1415921","article-title":"Troponin and cardiac events in stable ischemic heart disease and diabetes.","volume":"373","author":"Everett","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"jrv220002r34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7326\/M21-1499","article-title":"Performance of the European Society of cardiology 0\/1-hour, 0\/2-hour, and 0\/3-hour algorithms for rapid triage of acute myocardial infarction : an international collaborative meta-analysis.","volume":"175","author":"Chiang","year":"2022","journal-title":"Ann Intern Med"},{"issue":"14","key":"jrv220002r35","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1415516","article-title":"Outcomes of anatomical versus functional testing for coronary artery disease.","volume":"372","author":"Douglas","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"jrv220002r36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jacc.2019.12.012","article-title":"Coronary CT angiography in patients with non-ST-segment elevation acute coronary syndrome.","volume":"75","author":"Linde","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"9351","key":"jrv220002r37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"issue":"7","key":"jrv220002r38","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurheartj\/ehz595","article-title":"16-Year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.","volume":"41","author":"Thrane","year":"2020","journal-title":"Eur Heart J"},{"issue":"15","key":"jrv220002r39","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1056\/NEJMoa1301092","article-title":"Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.","volume":"368","author":"Armstrong","year":"2013","journal-title":"N Engl J Med"},{"issue":"15","key":"jrv220002r40","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete revascularization with multivessel PCI for myocardial infarction.","volume":"381","author":"Mehta","year":"2019","journal-title":"N Engl J Med"},{"key":"jrv220002r41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011986.pub2","article-title":"Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.","volume":"5","author":"Bravo","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"jrv220002r42","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.jcin.2020.04.055","article-title":"Multivessel versus culprit-only revascularization in STEMI and multivessel coronary artery disease: meta-analysis of randomized trials.","volume":"13","author":"Atti","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"jrv220002r43","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1001\/jama.2021.18323","article-title":"Cardiogenic shock after acute myocardial infarction: a review.","volume":"326","author":"Samsky","year":"2021","journal-title":"JAMA"},{"issue":"7","key":"jrv220002r44","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jacc.2006.06.050","article-title":"Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials.","volume":"48","author":"Bavry","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"jrv220002r45","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.","volume":"367","author":"Roe","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"jrv220002r46","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jacc.2016.01.034","article-title":"Spontaneous MI after non-ST-segment elevation acute coronary syndrome managed without revascularization: the TRILOGY ACS trial.","volume":"67","author":"Lopes","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"jrv220002r47","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction.","volume":"312","author":"Maddox","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"jrv220002r48","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.pcad.2020.05.013","article-title":"Special article: acute myocardial injury in patients hospitalized with COVID-19 infection: a review.","volume":"63","author":"Bavishi","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"issue":"8607","key":"jrv220002r49","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0140-6736(88)92833-4","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.","volume":"2","author":"ISIS-2 Collaborative Group","year":"1988","journal-title":"Lancet"},{"issue":"7","key":"jrv220002r50","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"issue":"20","key":"jrv220002r51","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes.","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"jrv220002r52","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes.","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"9219","key":"jrv220002r53","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.","volume":"355","author":"Eikelboom","year":"2000","journal-title":"Lancet"},{"issue":"9921","key":"jrv220002r54","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"24","key":"jrv220002r55","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1161\/CIR.0b013e318202f701","article-title":"ACCF\/ACG\/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.","volume":"122","author":"Abraham","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"jrv220002r56","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1161\/CIRCRESAHA.114.302737","article-title":"Antiplatelet and anticoagulation therapy for acute coronary syndromes.","volume":"114","author":"Bhatt","year":"2014","journal-title":"Circ Res"},{"issue":"15","key":"jrv220002r57","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2021.0716","article-title":"Oral antiplatelet therapy after acute coronary syndrome: a review.","volume":"325","author":"Kamran","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"jrv220002r58","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jama.284.12.1549","article-title":"Current role of platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes.","volume":"284","author":"Bhatt","year":"2000","journal-title":"JAMA"},{"issue":"11","key":"jrv220002r59","doi-asserted-by":"publisher","first-page":"e2134322","DOI":"10.1001\/jamanetworkopen.2021.34322","article-title":"Assessment of pretreatment with oral P2Y12 inhibitors and cardiovascular and bleeding outcomes in patients with non-ST elevation acute coronary syndromes: a systematic review and meta-analysis.","volume":"4","author":"Dawson","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9986","key":"jrv220002r60","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/S0140-6736(15)60292-6","article-title":"Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.","volume":"385","author":"Valgimigli","year":"2015","journal-title":"Lancet"},{"key":"jrv220002r61","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.ijcard.2016.07.228","article-title":"Radial access in patients with acute coronary syndrome without persistent ST-segment elevation: systematic review, collaborative meta-analysis, and meta-regression.","volume":"222","author":"And\u00f2","year":"2016","journal-title":"Int J Cardiol"},{"issue":"20","key":"jrv220002r62","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease.","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"issue":"10","key":"jrv220002r63","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.","volume":"363","author":"Mehta","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"jrv220002r64","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.120.050438","article-title":"Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective: 2021 update.","volume":"143","author":"Angiolillo","year":"2021","journal-title":"Circulation"},{"issue":"9","key":"jrv220002r65","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.amjcard.2015.02.003","article-title":"Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention.","volume":"115","author":"D\u2019Ascenzo","year":"2015","journal-title":"Am J Cardiol"},{"issue":"16","key":"jrv220002r66","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation.","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"jrv220002r67","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamacardio.2019.1880","article-title":"Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized controlled trials.","volume":"4","author":"Lopes","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"16","key":"jrv220002r68","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017212","article-title":"Safety and efficacy of double antithrombotic therapy with non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention: a systematic review and meta-analysis.","volume":"9","author":"Capodanno","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"16","key":"jrv220002r69","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation.","volume":"380","author":"Lopes","year":"2019","journal-title":"N Engl J Med"},{"issue":"25","key":"jrv220002r70","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI.","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"jrv220002r71","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jamacardio.2018.1086","article-title":"Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment.","volume":"3","author":"McCarthy","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"15","key":"jrv220002r72","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/j.jacc.2019.01.031","article-title":"Left ventricular thrombus: contemporary etiologies, treatment strategies, and outcomes.","volume":"73","author":"McCarthy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"jrv220002r73","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes.","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"issue":"25","key":"jrv220002r74","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes.","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"issue":"22","key":"jrv220002r75","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome.","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"jrv220002r76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia.","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"9266","key":"jrv220002r77","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"issue":"22","key":"jrv220002r78","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1161\/01.CIR.97.22.2202","article-title":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials.","volume":"97","author":"ACE Inhibitor Myocardial Infarction Collaborative Group","year":"1998","journal-title":"Circulation"},{"issue":"10","key":"jrv220002r79","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"jrv220002r80","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms.","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"issue":"14","key":"jrv220002r81","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1056\/NEJM198104023041401","article-title":"Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.","volume":"304","author":"Norwegian Multicenter Study Group","year":"1981","journal-title":"N Engl J Med"},{"issue":"13","key":"jrv220002r82","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"issue":"22","key":"jrv220002r83","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehp301","article-title":"Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study.","volume":"30","author":"Montalescot","year":"2009","journal-title":"Eur Heart J"},{"issue":"11","key":"jrv220002r84","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure.","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"20","key":"jrv220002r85","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","article-title":"Angiotensin receptor\u2013neprilysin inhibition in acute myocardial infarction.","volume":"385","author":"Pfeffer","year":"2021","journal-title":"N Engl J Med"},{"issue":"13","key":"jrv220002r86","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"\u00df-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"jrv220002r87","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100933","article-title":"SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: a systematic review and meta-analysis.","volume":"36","author":"Cardoso","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"10254","key":"jrv220002r88","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"jrv220002r89","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"issue":"11","key":"jrv220002r90","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis.","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"issue":"12","key":"jrv220002r91","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"issue":"19","key":"jrv220002r92","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.jacc.2015.02.063","article-title":"Gaps in referral to cardiac rehabilitation of patients undergoing percutaneous coronary intervention in the United States.","volume":"65","author":"Aragam","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"jrv220002r93","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/eurheartj\/ehv443","article-title":"Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.","volume":"37","author":"Udell","year":"2016","journal-title":"Eur Heart J"},{"issue":"15","key":"jrv220002r94","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/CIRCULATIONAHA.120.046308","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis.","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"jrv220002r95","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jamacardio.2016.1017","article-title":"Long-term tolerability of ticagrelor for the secondary prevention of major adverse cardiovascular events: a secondary analysis of the PEGASUS-TIMI 54 trial.","volume":"1","author":"Bonaca","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"19","key":"jrv220002r96","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction.","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"issue":"10073","key":"jrv220002r97","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"issue":"21","key":"jrv220002r98","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.jacc.2009.05.074","article-title":"The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis.","volume":"54","author":"Berger","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"jrv220002r99","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease.","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"jrv220002r100","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome.","volume":"366","author":"Mega","year":"2012","journal-title":"N Engl J Med"},{"issue":"23","key":"jrv220002r101","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1161\/CIRCULATIONAHA.120.046448","article-title":"Role of combination antiplatelet and anticoagulation therapy in diabetes mellitus and cardiovascular disease: insights from the COMPASS trial.","volume":"141","author":"Bhatt","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"jrv220002r102","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jacc.2021.04.083","article-title":"Mortality benefit of rivaroxaban plus aspirin in patients with chronic coronary or peripheral artery disease.","volume":"78","author":"Eikelboom","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"10117","key":"jrv220002r103","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0140-6736(17)32458-3","article-title":"Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.","volume":"391","author":"Connolly","year":"2018","journal-title":"Lancet"},{"issue":"10117","key":"jrv220002r104","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"jrv220002r105","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/CIRCULATIONAHA.118.038840","article-title":"Effect of alirocumab on mortality after acute coronary syndromes.","volume":"140","author":"Steg","year":"2019","journal-title":"Circulation"},{"issue":"18","key":"jrv220002r106","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1016\/j.jacc.2020.03.029","article-title":"Cost-effectiveness of alirocumab in patients with acute coronary syndromes: the ODYSSEY outcomes trial.","volume":"75","author":"Bhatt","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"jrv220002r107","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"},{"issue":"18","key":"jrv220002r108","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.121.057042","article-title":"Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial.","volume":"144","author":"Fr\u00f6bert","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"jrv220002r109","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2789023\/jama_bhatt_2022_rv_220002_1651499773.78755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T11:21:09Z","timestamp":1651576869000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2789023"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":109,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,2,15]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.0358","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,15]]}}}